Skip to main content
. 2020 Nov 3;21(21):8242. doi: 10.3390/ijms21218242

Figure 5.

Figure 5

Mean change from baseline in visual acuity (VA) and number of intravitreal injections (IVI) in real-world studies and randomized controlled trials after 12 months of ranibizumab treatment in patients with neovascular age related macular degeneration. Real world studies results have been adapted from Chong [27] and Kim et al. [153]. RLS: Real-life studies; gm: grand means (mean of the means of the several studies); wm: weighted means (mean weighted against number of eyes per study).